This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Ocular Melanoma
Information about Ocular Melanoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Ocular Melanoma
Most recent studies have shown that Ocular Melanoma shares some biological mechanisms with carcinoma, choroid-melanoma, choroid-neoplasms, conjunctival-neoplasms, cutaneous-melanoma, dental-plaque, eye-neoplasms, liver-neoplasms, malignant-neoplasms, malignant-paraganglionic-neoplasm, melanocytic-nevus, melanoma, metastatic-malignant-neoplasm-to-the-liver, metastatic-melanoma, neoplasm-metastasis, neoplasms, skin-neoplasms, uveal-melanoma, uveal-neoplasms.
Among the many pathways, these few ones have gauged particular interests from scientists studying Ocular Melanoma, and have been seen in publications frequently: Aging, Angiogenesis, Cell Death, Cell Growth, Cell Migration, Cell Proliferation, Cytolysis, Drug Resistance, Enucleation, Fibroblast Proliferation, Immune Response, Localization, Oncogenesis, Pathogenesis, Pigmentation, Programmed Cell Death, Response To Peptide, Transport, Transposition, Tube Formation
Quite a number of genes have been found to play important roles in Ocular Melanoma, such as ANKRD36B, BRAF, BRCA1, CD80, CDKN2A, ESR1, IL2, KIT, MAGEA3, MLANA, MME, PDCD6IP, PMEL, TNF, TNFSF14, TYR, VEGFA, ZNF654. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.